Fate Therapeutics
FATE
A$1.96
Share price
-8.93%
Change (1 day)
-65.34%
Change (1 year)
Categories
Fate Therapeutics (FATE) Fails to deliver data
Key failure to deliver metrics for Fate Therapeutics :
- Last SEC data release: 2025-05-14
- Last 15 days FTD volume: A$0.06 M
- Last 3 months FTD volume: A$0.53 M
- Last year FTD volume: A$0.53 M
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Fate Therapeutics (FATE) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Fate Therapeutics (FATE) - since 2013
Volume in USD (price x number of shares), data since 2013Fate Therapeutics (FATE) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2025 | A$0.6 M | -49.9% |
| 2024 | A$1.2 M | -44.15% |
| 2023 | A$2.15 M | -89.19% |
| 2022 | A$19.92 M | -20.28% |
| 2021 | A$24.99 M | 31.2% |
| 2020 | A$19.05 M | 9.95% |
| 2019 | A$17.32 M | 59.52% |
| 2018 | A$10.86 M | 1415.4% |
| 2017 | A$0.71 M | 181.93% |
| 2016 | A$0.25 M | -79.05% |
| 2015 | A$1.21 M | -17.49% |
| 2014 | A$1.47 M | -81.78% |
| 2013 | A$8.07 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | A$9.3 M | A$42.99 M | 🇺🇸 USA |
 Becton Dickinson BDX | A$6.59 M | A$57.39 M | 🇺🇸 USA |
 PTC Therapeutics
PTCT | A$1.39 M | A$31.57 M | 🇺🇸 USA |
 Avidity Biosciences RNA | A$7.12 M | A$20.75 M | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | A$12.48 M | A$28.83 M | 🇺🇸 USA |